Share on StockTwits

iBio (NASDAQ:IBIO) major shareholder Carl Desantis sold 28,828 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $0.55, for a total value of $15,855.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of iBio (NASDAQ:IBIO) traded down 0.89% during mid-day trading on Tuesday, hitting $0.559. The stock had a trading volume of 182,344 shares. iBio has a 52 week low of $0.28 and a 52 week high of $0.85. The stock has a 50-day moving average of $0.4 and a 200-day moving average of $0.42. The company’s market cap is $36.0 million.

iBio, Inc is a biotechnology company focused on commercializing its technology, the iBioLaunch platform, for the production of biologics, including vaccines and therapeutic proteins.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.